17 results
8-K
EX-1.1
SYRS
Syros Pharmaceuticals Inc.
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
grievance or significant arbitration proceeding arising out of or under any collective bargaining agreement is so pending against the Company
425
SYRS
Syros Pharmaceuticals Inc.
5 Jul 22
Business combination disclosure
7:14am
Subsidiaries is a party to, bound by, or has a duty to bargain under, any collective bargaining agreement or other Contract with a labor organization
8-K
EX-10.4
SYRS
Syros Pharmaceuticals Inc.
5 Jul 22
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
7:07am
subsidiaries is a party to or bound by any collective bargaining agreements or other agreements with labor organizations. To the Company’s Knowledge, neither … the Company nor any of its subsidiaries has violated in any material respect any laws, regulations, orders or contract terms affecting the collective
8-K
EX-2.1
kfqwkw1f9fr fvdmj14
5 Jul 22
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
7:07am
8-K
EX-1.1
lnpsg8d7t3gos
20 Jan 21
Syros Announces Proposed Offering of Common Stock
4:04pm
8-K
EX-10.1
2ch 8jovka44we0w48d
7 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-1.1
opvjck49gcte55rludw5
8 Apr 19
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.2
3x3mzgpx3ggu6uybikx8
8 Apr 19
Entry into a Material Definitive Agreement
12:00am
10-K
vmt mo84iex0ts
20 Mar 17
Annual report
12:00am
- Prev
- 1
- Next